Coston McIsaac & Partners’s Northwest Biotherapeutics, Inc. Common stock NWBO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $0 | Buy |
+1,000
| New | – | ﹤0.01% | 856 |
|
|
2025
Q1 | – | Sell |
-1,000
| Closed | – | – | 861 |
|
|
2024
Q4 | $0 | Hold |
1,000
| – | – | ﹤0.01% | 858 |
|
|
2024
Q3 | $0 | Hold |
1,000
| – | – | ﹤0.01% | 839 |
|
|
2024
Q2 | $0 | Hold |
1,000
| – | – | ﹤0.01% | 823 |
|
|
2024
Q1 | $0 | Hold |
1,000
| – | – | ﹤0.01% | 804 |
|
|
2023
Q4 | $0 | Hold |
1,000
| – | – | ﹤0.01% | 800 |
|
|
2023
Q3 | $0 | Buy |
+1,000
| New | – | ﹤0.01% | 821 |
|